Nazzi Gianfranco

Track

Insider profile

Nazzi Gianfranco's trades of Teva Pharmaceutical Industries Ltd's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2021-03-08 2021-03-04
PlS Planned sale
27,307 -36.7%
259.53
US$1,394,899 		27,307 -36.7% 259.53 US$1,394,899
2021-03-04 2021-03-03
PlS Planned sale
19,610 -8.6%
239.32
US$631,085 		19,610 -8.6% 239.32 US$631,085
2021-03-02 2021-03-01
PlS Planned sale
3,768 +24.3%
322.50
US$4,307,308 		3,768 +24.3% 322.50 US$4,307,308
2021-03-02 2021-03-01
PlS Planned sale
15,177 -20.1%
10.85
US$164,684 		15,177 -20.1% 10.85 US$164,684
2021-02-11 2021-02-09
PlS Planned sale
17,480 -22.4%
12.72
US$222,361 		17,480 -22.4% 12.72 US$222,361
2021-02-11 2021-02-09
PlS Planned sale
4,155 -5.1%
12.72
US$52,855 		4,155 -5.1% 12.72 US$52,855
2020-03-19 2020-03-17
PlS Planned sale
345 -1.7%
7.17
US$2,474 		345 -1.7% 7.17 US$2,474
2020-03-05 2020-03-03
PlS Planned sale
548 -2.8%
11.77
US$6,448 		548 -2.8% 11.77 US$6,448
2020-02-11 2020-02-10
PlS Planned sale
4,155 -18.4%
12.24
US$50,864 		4,155 -18.4% 12.24 US$50,864
2019-09-20 2019-09-18
S Sale
962 -8.3%
7.82
US$7,523 		962 -8.3% 7.82 US$7,523
2019-03-19 2019-03-18
S Sale
320 -3.4%
16.64
US$5,326 		320 -3.4% 16.64 US$5,326
2019-03-14 2019-03-12
S Sale
325 -3.7%
15.69
US$5,099 		325 -3.7% 15.69 US$5,099
2019-03-05 2019-03-04
S Sale
512 -6.1%
16.88
US$8,645 		512 -6.1% 16.88 US$8,645
2018-09-20 2018-09-18
S Sale
1,379 -16.4%
23.69
US$32,670 		1,379 -16.4% 23.69 US$32,670
2018-03-20 2018-03-19
S Sale
457 -7.4%
17.89
US$8,177 		457 -7.4% 17.89 US$8,177
2018-03-14 2018-03-12
S Sale
461 -8.0%
19.50
US$8,989 		461 -8.0% 19.50 US$8,989